FDA needs more funding, NEJM says, amid questions about antidiabetes drug

BMJ. 2007 Aug 18;335(7615):322. doi: 10.1136/bmj.39304.603762.DB.
No abstract available

Publication types

  • News

MeSH terms

  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / economics
  • Financing, Government
  • Humans
  • Hypoglycemic Agents / economics*
  • United States
  • United States Food and Drug Administration / economics*

Substances

  • Hypoglycemic Agents